NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.220
+0.130 (6.22%)
At close: Feb 6, 2026, 4:00 PM EST
2.250
+0.030 (1.35%)
After-hours: Feb 6, 2026, 7:47 PM EST
NuCana Market Cap
NuCana has a market cap or net worth of $9.24 million as of February 6, 2026. Its market cap has increased by 114.87% in one year.
Market Cap
9.24M
Enterprise Value
-24.52M
1-Year Change
114.87%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $9.24M, a decrease of -98.20%. That is a compound annual growth rate of -38.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 9.20M | -38.67% |
| Dec 31, 2025 | 15.00M | 219.15% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 9.90M |
| GridAI Technologies | 9.78M |
| Chemomab Therapeutics | 9.42M |
| Edesa Biotech | 9.33M |
| Evogene | 9.25M |
| BioRestorative Therapies | 9.23M |
| Pulmatrix | 9.06M |
| SeaStar Medical Holding | 8.94M |